MDisrupt Webinars


How will value-based care drive digital health companies to show outcomes and improve evidence generation?

Date: April 13, 2021
Time: 11:00AM – 12:00PM PST

By 2026, health systems will need to show a shift from a fee-for-service model to a value-based care model. This will require health systems, payers, and digital health companies to work together to determine what evidence is needed to demonstrate outcomes. Where do health systems and payers even start in tackling this challenge? It’s all in the numbers . . .

In this webinar, we will cover:

  • What does value-based care mean and what challenges does it pose to our current healthcare ecosystem?
  • What evidence will digital health companies need to generate to convince payers, providers, and health systems in a value-based care setting?
  • What types of outcomes do health systems and payers care about measuring?
  • What types of studies should digital health companies be conducting?
  • What do digital health companies need to do differently to increase their chances of adoption in value-based care settings?


Corinne Stroum, MS (Moderator)

Vice President for Utilization and Cost Solutions, KenSci Extension Lecturer, University of Washington, Methods & Applications of Healthcare Analytics

James Grana, PhD

Chief of Contracting and Network Development Divisions at Rush Health

Eric J. Daza, DrPH, MPS

Lead Biostatistician (Data Science) at Evidation Health

Danish Nagda, MD, MBA

Founder & CEO at Rezilient Health

mdisrupt-webinar-digital health regulation

How will regulation of digital health products be impacted with the new administration?

Date: March 9, 2021
Time: 11:00AM – 12:00PM PST

With the transition to the Biden-Harris Administration, appointing new leadership within the healthcare focused agencies, and the swearing in of the new Congress, the precision medicine industry can expect new attention to critical policy issues including regulation of diagnostic testing, digital health platforms, and at home testing. Is your regulatory team prepared for these changes?

In this webinar, we will cover:

  • What are the priorities of the incoming administration and new Congress?
  • How will these priorities shift the way the FDA is thinking about regulating laboratory developed tests and digital health software?
  • How should regulatory teams in digital health companies start to prepare for these shifts?
  • How will your legal team be thinking about recently implemented regulations during and after the transition?


Jennifer Leib Sc.M., C.G.C. (Moderator)

Founder at Innovation Policy Solutions

Marissa Cruz M.D.

Executive Vice President for Clinical and Regulatory Affairs at Everlywell

Kevin Coker M.S., M.P.H., J.D.

Co-Founder and CEO of Proxima Clinical Research

Delphine O’Rourke J.D.

Partner at Goodwin

A Healthy Disruption 02

Reimagining Population Health Management

Can Genomics Evolve our Sick Care System into a True Healthcare System

Date: December 15, 2020
Time: 11:30 am – 12:30 pm PST

Imagine if our healthcare system could actually prevent us from becoming patients in the first place.

In today’s healthcare, we use only 10% of the data that predicts health outcomes. Genetic information has the potential to radically improve our predictive power and to help risk-stratify the patients at highest and lowest risk of common chronic diseases such as diabetes, cardiovascular disease, and hypertension.

This webinar will explore how using genetics as a routine part of our healthcare can help us improve population health management—by identifying the highest-risk patients and proactively delivering personalized, preventive interventions to the right patients at the right time.

Key themes

  • The channels, tools, and delivery methods that could be used for population health management;
  • How genomics can be paid for when applied as a population health management tool in the transition to value-based care; and
  • How digital health companies should think about building solutions for population health management.


Lisa Alderson (Moderator)

CEO and Co-Founder of Genome Medical

Tony Slonim, MD, DrPH, FACHE

President and CEO, Renown Health

Chet Robson, DO, MHCDS, FAAFP

Chief Clinical Officer, Walgreens

Professor Sir Peter Donnelly, FRS FMedSci

Founder and CEO, Genomics plc

Marcia Guida, MS-CH, MBA, MS-HP,CPC

Senior Director, Value Based Contracting and Medicare Network Operations, Aetna CVS Health

A Healthy Disruption

Social Determinants of Health in the Virtual Care Setting

Date: November 17, 2020
Time: 11:00 am – 12:00 pm PST

In the time of COVID-19, digital health and telehealth capacities are ramping up. These technologies often point to solutions for specific chronic conditions. In this webinar, learn from experts about:

  • How chronic conditions are often underpinned by behavioral complexities such as smoking, diet, alcohol use, physical activity, etc.
  • How digital and healthtech companies can integrate behavioral, social, and clinical care data into product design to create context-aware, intelligent solutions


Kate Wolin, ScD, FACSM, FSBM (Moderator)

Entrepreneurial Executive and Behavioral Epidemiologist

Gina Merchant, Ph.D.

Behavioral Scientist

Aditi U. Joshi MD, MSc, FACEP

Medical Director of JeffConnect

Gary Bennett, Ph.D.

Bishop-MacDermott Family Professor of Psychology & Neuroscience, Global Health and Medicine and Vice Provost for Undergraduate Education at Duke University

Share This